← Evidence map

ArticleCancers2025

The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).

Paula Llor-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). | OpenQuestion